Profile
ALVO TAK ZTS HLN TEVA VTRS
Company Name Alvotech Takeda Pharmaceutical Company Limited Zoetis Inc. Haleon plc Teva Pharmaceutical Industries Limited Viatris Inc.
Sector Healthcare Healthcare Healthcare Healthcare Healthcare Healthcare
Industry Drug Manufacturers - Specialty & Generic Drug Manufacturers - Specialty & Generic Drug Manufacturers - Specialty & Generic Drug Manufacturers - Specialty & Generic Drug Manufacturers - Specialty & Generic Drug Manufacturers - Specialty & Generic
Market Cap $1.62B $58.03B $55.37B $49.48B $38.97B $14.94B
Employees 1.01K 49.28K 13.80K 24.56K 37.00K 32.00K
CEO Vilhelm Robert Wessman Christophe Weber Kristin C. Peck Brian James McNamara Richard D. Francis Scott Andrew Smith
Ratings
ALVO TAK ZTS HLN TEVA VTRS
Quant Rating Score 2 3 3 4 3 2
Quant Rating Sell Neutral Neutral Buy Neutral Sell
Trading
ALVO TAK ZTS HLN TEVA VTRS
Last Close $5.14 $14.14 $118.8 $9.68 $24.59 $10.66
High 52 $13.52 $15.52 $178.71 $11.41 $25.83 $13.37
Low 52 $4.83 $12.89 $118.8 $8.73 $12.82 $7.26
Price vs. 52 Week High -61.98 % -8.89 % -33.52 % -15.16 % -4.8 % -20.27 %
Price vs. 52 Week Low 6.42 % 9.7 % 0 % 10.88 % 91.81 % 46.83 %
Total Return
ALVO TAK ZTS HLN TEVA VTRS
1 Month Return -41.06 % 0.71 % -17.53 % 2.11 % 27.34 % 4.82 %
3 Month Return -42.89 % -6.73 % -21.96 % -0.05 % 36.16 % 0.28 %
6 Month Return -50.86 % 0.21 % -27.13 % -10.37 % 45.16 % 20.59 %
9 Month Return -59.14 % 1.73 % -24.08 % -3.1 % 48.4 % -1.84 %
YTD Return -61.15 % 6.8 % -27.09 % 1.47 % 11.57 % -14.38 %
1 Year Return -58.88 % 3.82 % -32.33 % 2.11 % 46.28 % -18.31 %
3 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
5 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
Dividends
ALVO TAK ZTS HLN TEVA VTRS
Dividend Yield Percentage (TTM) - 3.53 % 1.62 % 1.41 % - 3.7 %
Dividend Paid and Capex Coverage Ration (TTM) -0.3 % 2.23 % 1.89 % 2.01 % 4 % 2.09 %
Dividend Per Share (TTM) - 198 % 2.03 % 0.06 % - 0.48 %
Payout Ratio (TTM) - 277.04 % 32.55 % 27.27 % - -15.34 %
Growth
ALVO TAK ZTS HLN TEVA VTRS
Asset Growth 28.56 % -0.34 % 0.76 % 3.61 % -12.97 %
Gross Profit Growth 538.44 % 9.63 % -0.19 % 10.86 % -12.66 %
Revenue Growth 435.56 % 8.33 % -0.61 % 4.32 % -4.46 %
Revenue 3 Year 55.32 % 24.31 % 19.01 % 11.71 % -16.52 %
Revenue 5 Year 1295.18 % 55.65 % 33.95 % -1.27 % -39.86 %
Revenue 10 Year 1295.18 % 113.39 % 33.95 % -34.65 % -36.45 %
EBIT Growth 87.72 % 5.67 % 13.52 % -9.52 % -109.43 %
Net Income Growth 57.98 % 6.06 % 37.46 % 185.97 % -1259.41 %
Net Income 3 Yeari Growth Per Share 73.36 % 27.46 % 4.91 % 155.65 % 49.38 %
Net Income 5 Yeari Growth Per Share -0.47 % 74.46 % 122.63 % 133.65 % -1871.56 %
Net Income 10 Yeari Growth Per Share -0.47 % 370.4 % 122.63 % -33.98 % -122.71 %
Operating Income Growth 119.63 % 10.52 % 10.52 % 1131.35 % -98.68 %
Operating Cash Flow Growth (CFG) 24.13 % 25.5 % 9.57 % -35.33 % -17.74 %
Operating 3 Year CFG 87.89 % 39.36 % 71.6 % 0.19 % -22.68 %
Operating 5 Year CFG -143.24 % 73.18 % 196.04 % 29.24 % -40.08 %
Operating 10 Year CFG -143.24 % 420.39 % 196.04 % -77.86 % -24.47 %
EPS Growth 64.2 % 7.68 % 33.33 % 184.83 % -1262.28 %
EPS Diluted Growth 64.2 % 7.89 % 33.33 % 182.76 % -1269.98 %
Book Value Per Share 62.45 % -2.96 % -1.63 % 36.19 % -8.42 %
Share Holder 3 Year Equity Growth Per Share 64.5 % 9.65 % -37.97 % -2.08 % -7.88 %
Share Holder 5 Year Equity Growth Per Share - 85.42 % -40.16 % -24.81 % -26.41 %
Share Holder 10 Year Equity Growth Per Share - 301.38 % -40.16 % -80.23 % 90.51 %
Dividend Per Share Growth - 15.33 % 49.01 % - 0.45 %
Dividend 3 Year Growth Per Share - 73.18 % -49.79 % - 45.93 %
Dividend 5 Year Growth Per Share - 163.51 % -49.97 % - -
Dividend 10 Year Growth Per Share - 493.89 % -49.97 % -100 % -
Debt Growth 10.67 % -0.16 % 6.83 % -3.86 % -22.13 %
Free Cash Flow Growth 18.07 % 41.76 % 16.27 % -43.99 % -14.98 %
Updated On 31 Dec 2024 31 Dec 2024 31 Dec 2024 31 Dec 2025 31 Dec 2024
Profitability
ALVO TAK ZTS HLN TEVA VTRS
Gross Profit Margin TTM 55.42 % 59.49 % 70.63 % 61.81 % 51.76 % 36.07 %
Return on Assets TTM 4.93 % 0.73 % 17.49 % 4.78 % 3.48 % -9.73 %
Return on Equity TTM -26.11 % 1.58 % 53.56 % 9.4 % 20.09 % -22.69 %
Return on Capital Employed TTM 3.93 % 3.59 % 26.48 % 8.34 % 11.54 % -8.43 %
Net Income Per EBT TTM 133.05 % 54.99 % 79.59 % 76.52 % 114.62 % 95.92 %
EBT Per Ebit TTM 120.22 % 44.75 % 94.2 % 88.09 % 39.3 % 149.32 %
EBIT Per Revenue TTM 7.61 % 10.28 % 37.63 % 20.49 % 18.15 % -18.25 %
Cash Flow To Debt Ratio TTM -2.07 % 23.13 % 40.09 % 12.02 % 11.62 % 13.47 %
Receivables Turnover TTM 4.71 5.89 6.1 5.14 4.68 3.94
Payables Turnover TTM 2.78 3.87 6.73 1.18 3.31 6.81
Inventory Turnover TTM 1.23 1.29 1.12 3.72 2.63 2.2
Fixed Asset Turnover TTM 115.58 % 214.23 % 241.44 % 589.57 % 392.13 % 488.38 %
Asset Turnover TTM 40.53 % 28.97 % 61.99 % 34.62 % 42.58 % 37.25 %
Operating Cash Flow Per Share TTM -0.09 710.55 6.58 0.11 1.76 1.7
Free Cash Flow Per Share TTM -0.38 589.53 5.06 0.1 1.32 1.37
Cash Per Share TTM 14.27 % 48236.45 % 470.54 % 7.46 % 309.55 % 99.36 %
Operating Cash Flow Sales Ratio TTM -4.64 % 25.14 % 31.03 % 9.32 % 11.64 % 14.04 %
Free Cash Flow Operating Cash Flow Ratio TTM 428.35 % 82.97 % 76.82 % 90.65 % 74.99 % 80.65 %
Cash Flow Coverage Ratios TTM -2.07 % 23.13 % 40.09 % 12.02 % 11.62 % 13.47 %
Price To Free Cash Flows Ratio TTM -14.28 9.52 24.72 38.08 25.61 9.34
Price To Operating Cash Flows Ratio TTM -58.95 7.9 19.08 35.1 19.24 7.62
Price Cash Flow Ratio TTM -58.95 7.9 19.08 35.1 19.24 7.62
Income Statement (TTM)
ALVO TAK ZTS HLN TEVA VTRS
Revenue $0.49B $4581.55B $9.47B $11.23B $17.26B $14.74B
Gross Profit $0.3B $3001.33B $0B $6.95B $8.94B $5.62B
Gross Profit Ratio 62.16% 65.51% 0% 61.85% 51.79% 38.15%
EBITDA $-0.03B $1210.51B $0B $2.51B $3.14B $2.82B
Net Income $-0.23B $107.93B $2.67B $1.44B $1.41B $-0.63B
EPS Diluted -0.87 33.62 6.02 0.32 1.2 -0.53
Balance Sheet (MRQ)
ALVO TAK ZTS HLN TEVA VTRS
Long Term Debt $1.15B $3966.33B $0.2B $8.62B $15.56B $14.22B
Total Liabilities $1.63B $7312.37B $12.14B $18.09B $32.83B $22.87B
Total Equity $-0.41B $6935.98B $3.33B $16.22B $7.91B $18.64B
Total Investments $0.02B $382.4B $0B $0.14B $0B $1.7B
Total Debt $1.19B $4515.27B $0.2B $10.1B $17.38B $14.31B
Total Assets $1.22B $14248.34B $15.47B $34.32B $40.75B $41.5B
Cash Flow Statement (TTM)
ALVO TAK ZTS HLN TEVA VTRS
Net Income $-0.23B $107.93B $2.67B $1.44B $1.42B $-0.63B
Inventory $-0.05B $-34.97B $-0.2B $0.22B $0.15B $-0.72B
Dividends Paid $0B $-302.5B $-0.89B $-0.57B $0B $-0.57B
Operating Cash Flow $-0.24B $1057.18B $2.9B $2.3B $1.65B $2.3B
Capital Expenditure $-0.06B $-200.8B $-0.62B $-0.25B $-0.5B $-0.33B
Related Stocks
Ticker Name Price
ACB Aurora Cannabis Inc. 3.55
ACOR Acorda Therapeutics, Inc. 0.661
ACRX AcelRx Pharmaceuticals, Inc. 0.86
ADMP Adamis Pharmaceuticals Corporation 0.775
ADMS Adamas Pharmaceuticals, Inc. 8.22
AERI Aerie Pharmaceuticals, Inc. 15.25
AGRX Agile Therapeutics, Inc. 1.51
AKAN Akanda Corp. 0.8964
ALIM Alimera Sciences, Inc. 5.54
ALVOW Alvotech 0.3025
AMPH Amphastar Pharmaceuticals, Inc. 28.5
AMRX Amneal Pharmaceuticals, Inc. 14.82
AMYT Amryt Pharma plc 14.7
ANIP ANI Pharmaceuticals, Inc. 77.36
APUS Apimeds Pharmaceuticals US, Inc 1.23
AQST Aquestive Therapeutics, Inc. 3.65
ASRT Assertio Holdings, Inc. 12.375
ATNX Athenex, Inc. 0.2031
AVDL Avadel Pharmaceuticals plc 21.64
AYTU Aytu BioPharma, Inc. 2.13
ETFs With Exposure to ALVO
Ticker ETF Name Weight Percentage Price
VWO Vanguard Emerging Markets Stock Index Fund 0.00508 57.75
IBB iShares Biotechnology ETF 0.05 172.55
VEU Vanguard FTSE All-World ex-US Index Fund 0.00151 80.48
VT Vanguard Total World Stock Index Fund 0.0005 146.34
VXUS Vanguard Total Intl Stock Idx Fund 0.00134 82.4
SCHE Schwab Emerging Markets Equity ETF 0.00543438 35.2
PRFZ Invesco FTSE RAFI US 1500 Small-Mid ETF 0.010102 48.4559
BIB ProShares Ultra Nasdaq Biotechnology 0.0797162 84.7191
ONEQ Fidelity Nasdaq Composite Index ETF 0.01 88.7542
DWAS Invesco DWA SmallCap Momentum ETF 0.199 100.36
FPXE First Trust IPOX Europe Equity Opportunities ETF 0.12 32.852
PZW.TO Invesco FTSE RAFI Global Small-Mid ETF 0.0037 44.33
VEE.TO Vanguard FTSE Emerging Markets All Cap Index ETF 0.005 47.29
VXC.TO Vanguard FTSE Global All Cap ex Canada Index ETF 0.00054 75.84
IDNA iShares Genomics Immunology and Healthcare ETF 0.55 29.06
VSGX Vanguard ESG International Stock ETF 0.00198 78.18
VGRO.TO Vanguard Growth ETF Portfolio 0.00028 44.16
VEQT.TO Vanguard All-Equity ETF Portfolio 0.00035 55.46
VBAL.TO Vanguard Balanced ETF Portfolio 0.00022 37.77
VCNS.TO Vanguard Conservative ETF Portfolio 0.00015 32.11
VCIP.TO Vanguard Conservative Income ETF Portfolio 0.00008 27.4
VRIF.TO Vanguard Retirement Income ETF Portfolio 0.00006 27.01
SPAK Defiance Next Gen SPAC Derived ETF 0.14 14.63
IBBQ Invesco Nasdaq Biotechnology ETF 0.114325 29.429
2B70.DE iShares Nasdaq US Biotechnology UCITS ETF USD (Acc) 0.11 7.345
VFEA.DE Vanguard FTSE Emerging Markets UCITS ETF 0.00542 71.43
VWCE.DE Vanguard FTSE All-World UCITS ETF 0.00073 147.7
VWRA.L Vanguard FTSE All-World UCITS ETF 0.00073 175.46
VWRD.L Vanguard FTSE All-World UCITS ETF 0.00073 171.17
BTEC.L iShares Nasdaq US Biotechnology UCITS ETF USD (Acc) 0.11 8.7175
SBIO.MI Invesco NASDAQ Biotech UCITS ETF 0.1146 52.57
VFEA.L Vanguard FTSE Emerging Markets UCITS ETF 0.00542 84.81
VTSNX Vanguard Total Intl Stock Idx Fund 0.00134 176.94
BTEE.L iShares Nasdaq US Biotechnology UCITS ETF 0.11 8.684
VFEM.L Vanguard FTSE Emerging Markets UCITS ETF 0.00542 59.025
SBIO.L Invesco NASDAQ Biotech UCITS ETF 0.1146 62.41
STXK Ea Series Trust - Strive 2000 ETF 0.03 35.58
VFWAX Vanguard FTSE All-World ex-US Index Fd Admiral 0.00151 49.9
VEMAX Vanguard Emerging Markets Stock Index Fund Admiral Shares 0.00508 47.82
V3AB.L Vanguard Funds Public Limited Company - Vanguard ESG Global All Cap UCITS ETF 0.00058 5.819
VWRL.L Vanguard Funds Public Limited Company - Vanguard FTSE All-World UCITS ETF 0.00073 125.55
V3AM.L Vanguard ESG Global All Cap UCITS ETF 0.00058 5.437
VFEG.L Vanguard FTSE Emerging Markets UCITS ETF 0.00542 62.03
V3AA.L Vanguard Funds Public Limited Company - Vanguard ESG Global All Cap UCITS ETF 0.00058 7.935
VDEM.L Vanguard FTSE Emerging Markets UCITS ETF 0.00542 80.37
BTEK.L iShares Nasdaq US Biotechnology UCITS ETF USD (Acc) 0.11 6.3925
V3AL.L Vanguard Funds Public Limited Company - Vanguard ESG Global All Cap UCITS ETF 0.00058 7.405
VWRP.L Vanguard Funds Public Limited Company - Vanguard FTSE All-World UCITS ETF 0.00073 128.6
VTIAX Vanguard Total International Stock Index Fd Admiral 0.00134 44.24
VTWAX Vanguard Total World Stock Index Fund Admiral Shares 0.0005 51.77
VFEM.DE Vanguard FTSE Emerging Markets UCITS ETF 0.00542 67.77
VGWL.DE Vanguard FTSE All-World UCITS ETF 0.00073 144.22
VEU.AX Vanguard All-World ex-US Shares Index ETF 0.00151 113.4
VGE.AX Vanguard FTSE Emerging Markets Shares ETF 0.00508 89.97
VWRL.AS Vanguard FTSE All-World UCITS ETF 0.00073 144.2
FTWD.DE Invesco FTSE All-World UCITS ETF 0.0002 6.999
FWRA.MI Invesco FTSE All-World UCITS ETF 0.0002 7.275
VEMRX Vanguard Emerging Mkts Stock Idx InsPlus 0.00508 120.96
FWRA.SW Invesco FTSE All-World UCITS ETF 0.0002 6.638
FWRG.L Invesco FTSE All-World UCITS ETF USD Accumalation 0.0002 633.4
FTWG.L Invesco FTSE All-World UCITS ETF USD Distribution 0.0002 609.8
VTWIX Vanguard Total World Stock Index I 0.0005 298.44
VTPSX Vanguard Total Intl Stock Idx InstlPls 0.00134 176.98
RFLR Innovator ETFs Trust 0.02 29.59
VFEM.AS Vanguard FTSE Emerging Markets UCITS ETF USD Distributing 0.00542 67.54
GLCR GlacierShares Nasdaq Iceland ETF 4.25 27.8382
VWRL.SW Vanguard FTSE All-World UCITS ETF (USD) Distributing 0.00073 131.46
VEXC Vanguard World Funds 0.00677 87.86
FWRA.L Invesco FTSE All-World UCITS ETF USD Accumalation 0.0002 8.638
Unlock